NARI(Delisted)
Inari Medical·NASDAQ
--
--(--)
NARI fundamentals
Inari Medical (NARI) Revenue Breakdown: Q3 2024 Business & Regional Performance
Inari Medical (NARI) reported total revenue of 153.39M USD in Q3 2024, with its core business segment Venous Thromboembolism contributing 94.76%. Regionally, United States remained the largest market, accounting for 92.48% of total revenue. Explore Inari Medical's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Inari Medical (NARI) reported total revenue of 153.39M USD in Q3 2024, with its core business segment Venous Thromboembolism contributing 94.76%. Regionally, United States remained the largest market, accounting for 92.48% of total revenue. Explore Inari Medical's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
No Data
